On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: A review

International Journal of Pharmaceutics

Volumn 456, Issue 2, 2013, Pages 340-352

  Pippa, Natassa ^a   Dokoumetzidis, Aristides ^a   Demetzos, Costas ^a   Macheras, Panos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Advanced Drug Delivery nano Systems (aDDnSs); Biopharmaceutics; Fractal analysis; Morphology; Nanotechnology; Pharmacokinetics

Indexed keywords

ANALYTIC METHOD; CALIBRATION; CONFOCAL LASER MICROSCOPY; DENSITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG RELEASE; DRUG SOLUBILITY; DYNAMIC LIGHT SCATTERING; DYNAMIC RHEOLOGICAL MEASUREMENT; ELECTRON MICROSCOPY; ENZYME KINETICS; FRACTAL ANALYSIS; GEOMETRY; HYDRODYNAMICS; HYDROPHILICITY; METABOLISM; MOLECULAR WEIGHT; NANOTECHNOLOGY; NEUTRON SCATTERING; NONLINEAR SYSTEM; PARTICLE SIZE; PHARMACEUTICS; POROSITY; PRIORITY JOURNAL; REVIEW; SEDIMENTATION; STATIC LIGHT SCATTERING; SURFACE PROPERTY; WIDE ANGLE X RAY DIFFRACTION; X RAY CRYSTALLOGRAPHY;

1,2-DIOLEOYL-3-DIMETHYLAMMONIUM-PROPANE; 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; ABSORPTION, BIODISTRIBUTION, METABOLISM AND EXCERTION; ADDNSS; ADME; ADVANCED DRUG DELIVERY NANO SYSTEMS; ADVANCED DRUG DELIVERY NANO SYSTEMS (ADDNSS); BIOPHARMACEUTICS; DIFFUSION LIMITED AGGREGATION; DLA; DODAP; DPPC; DPPG; FBS; FETAL BOVINE SERUM; FRACTAL ANALYSIS; MLCRSS; MODULATORY LIPOSOMAL CONTROLLED RELEASED SYSTEMS; MORPHOLOGY; NANOTECHNOLOGY; PBS; PD; PHARMACODYNAMICS; PHARMACOKINETICS; PHOSPHATE BUFFER SALINE; PK; REACTION LIMITED CLUSTER AGGREGATION; RLCA;

ANIMALS; FRACTALS; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84886723061     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.08.087     Document Type: Review

References (210)

1. N. Abdullah, A. Yuriz, T.P. Curtis, A. Yahya, and Z. Ujang Characterization of aerobic granular sludge treating high strength agro-based wastewater at different volumetric laodings Bioresour. Technol. 127 2013 181 187
2. A. Accardo, M. Affinito, M. Carrozzi, and F. Bouquet Use of fractal dimension for the analysis of electroencephalographic time series Biol. Cybern. 77 1997 339 350 (Pubitemid 127664737)
3. F. Alexis, E. Pridgen, L.K. Molnar, and O.K. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
4. G. Albrecht-Buehler Fractal genome sequences Gene 498 2012 20 27
5. T.M. Allen, W.W. Cheng, J.I. Hare, and K.M. Laginha Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer Anticancer Agents Med. Chem. 6 2006 513 523 (Pubitemid 44697110)
6. Z. Amoozgar, and Y. Yeo Recent advances in stealth coating of nanoparticles drug delivery systems Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2012 219 433
7. B.J. Anderson, and N.H. Holford Mechanistic basis of using body size and maturation to predict clearance in humans Drug Metab. Pharmacokinet. 24 2009 25 36
8. M.A. Aon, S. Cortassa, and D. Lloyd Chaotic dynamics and fractal space in biochemistry: simplicity underlies complexity Cell Biol. Int. 24 2000 581 587
9. M.A. Aon, B. O' Rourke, and S. Cortassa The fractal architecture of cytoplasmic organization: scaling, kinetics and emergence in metabolic networks Mol. Cell Biochem. 256-257 2004 169 184 (Pubitemid 38181243)
10. J.S. Aranda, E. Salgado, and A. Muñoz-Diosdado Multifractality in intracellular enzymatic reactions J. Theor. Biol. 240 2006 209 217
11. D. Avnir, D. Farin, and P. Pfeifer Molecular fractal surfaces Nature 308 1984 261 263
12. J.W. Baish, and R.K. Jain Fractals and cancer Cancer Res. 60 2000 3683 3688 (Pubitemid 32204551)
13. S.C. Balmert, and S.R. Little Biomimetic delivery with micro- and nanoparticles Adv. Mater. 24 2012 3757 3778
14. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
15. A. Bancaud, C. Lavelle, S. Huet, and J. Ellenberd A fractal model for nuclear organization: current evidence and biological implications Nucleic Acids Res. 40 18 2012 8783 8792
16. G. Bonacucina, M. Cepsi, M. Misici-Falsi, and G.F. Palmieri Colloidal Soft Matter as Drug Delivery System J. Pharm. Sci. 98 2009 1 42
17. H.G. Brittain, S.J. Bogdanowich, D.E. Bugay, J. DeVincentis, G. Lewen, and A.W. Newman Physical characterization of pharmaceutical solids Pharm. Res. 8 1991 963 973
18. V.Y. Brodsky Direct cell-cell communication: a new approach derived from recent data on the nature and self-organization of ultradian (circahoralian) intracellular rhythms Biol. Rev. Camb. Philos. Soc. 81 2006 143 162 (Pubitemid 43209224)
19. A. Brú, S. Albertos, J.L. Subiza, J.L. Carcía-Asenjo, and I. Brú The universal dynamics of tumor growth Biophy. J. 85 2003 2948 2961 (Pubitemid 37345785)
20. A. Bunde, S. Havlin, R. Nossal, H.E. Stanley, and G.H. Weiss On controlled diffusion-limited drug release from a leaky matrix J. Chem. Phys. 83 1985 5909 5913
21. G.C. Bushell, Y.D. Yan, D. Woodfield, J. Raper, and R. Amal On techniques for measurement of the mass fractal dimension of aggregation Adv. Colloid Interface Sci. 95 2002 1 50 (Pubitemid 33146968)
22. D.J. Burnett, J.Y. Heng, F. Thielmann, A.R. Garcia, M. Naderi, and M. Acharya Measuring surface roughness of pharmaceutical powders using vapor sorption methods AAPS Pharm. Sci. Tech. 12 2011 56 61
23. D.A. Canelas, K.P. Herlihy, and J.M. DeSimone Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1 2009 393 404
24. L. Cattel, M. Ceruti, and F. Dosio From conventional to stealth liposomes: a new frontier in cancer chemotherapy J. Chemother. 4 2004 94 97 (Pubitemid 40065293)
25. S.D. Caruthers, S.A. Wickline, and G.M. Lanza Nanotechnological applications in medicine Curr. Opin. Biotechnol. 18 2007 26 30 (Pubitemid 46227971)
26. G.F. Cerofini, D. Narducci, P. Amato, and E. Romano Fractal Nanotechnology Nanoscale Res. Lett. 3 2008 381 385
27. J.A. Champion, and S. Mitragotri Role of target geometry in phagocytosis Proc. Natl. Acad. Sci. U.S.A. 103 12 2006 4930 4934
28. J.A. Champion, Y.K. Katare, and S. Mitragotri Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers J. Control. Release 121 2007 3 9 (Pubitemid 47126059)
29. V. Chardot, S. Banon, M. Misiuwianiec, and J. Hardy Growth kinetics and fractal dimensions of casein particles during acidification J. Dairy Sci. 85 2002 8 14 (Pubitemid 38571491)
30. M.L. Chen Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective Adv. Drug Deliv. Rev. 60 2008 768 777
31. B. Chu, and T. Liu Characterization of nanoparticles by scattering techniques J. Nanopart. Res. 2 2000 29 41
32. A. Crivoi, and F. Duan Evaporation-induced formation of fractal-like structures from nanofluids Phys. Chem. Chem. Phys. 14 2012 1449 1454
33. D.J. Crommelin, and A.T. Florence Towards more effective advanced drug delivery systems Int. J. Pharm. 454 1 2013 496 511
34. S.S. Cross Fractals in pathology J. Pathol. 182 1997 1 8 (Pubitemid 27240443)
35. J.K. de Kruif, J. Khoo, R. Bravo, and M. Kuentz Novel quality by design toold for concentrated drug suspensions: surface energy profiling and the fractal concept of flocculation J. Pharm. Sci. 102 2013 994 1007
36. M.M. de Villires, P. Aramwit, and G.S. Know Nanotechnology in Drug Delivery. Biopharmaceutical Aspects 2009 Springer AAPS PRESS. American Association of Pharmaceutical Scientists, New York, U.S.A.
37. C. Demetzos Drug delivery nanosystems and their classification based on their dynamic variability 2nd International Symposium on Biological Applications of Dendrimers Porquerolles islands, France, June 23-26 2010
38. C. Demetzos Advances in drug delivery systems (DDSs) International Congress on New Delivery Systems, Biosimilars, Bioequivalence-Biowaivers- Biotechnology Products Athens, Greece, July 2-3 2010
39. C. Demetzos Drug Delivery nano Systems (DDnSs) and advances on their physical stability Dendrimers as Composites of Advanced Drug Delivery nano-Systems (aDDnSs) Biomedical Applications, October 3-7, Athens, Greece 2011
40. P. Dey Basic principle and applications of fractal geometry in pathology: a review Anal. Quant. Cytol. Histol. 27 2005 284 290 (Pubitemid 41504430)
41. A. Dokoumetzidis, A. Iliadis, and P. Macheras Nonlinear dynamics and chaos theory: concepts and applications relevant to pharmacodynamics Pharm. Res. 18 2001 415 426 (Pubitemid 32592571)
42. A. Dokoumetzidis, A. Iliadis, and P. Macheras Nonlinear Dynamics in Clinical Pharmacology: the paradigm of cortisol secretion and suppresion Br. Clin. Pharmacol. 54 2002 21 29 (Pubitemid 36124750)
43. A. Dokoumetzidis, and P. Macheras A model for transport and dispersion in the circulatory based on the vascular fractal tree Ann. Biomed. Eng. 31 2003 284 293
44. A. Dokoumetzidis, V. Karalis, A. Iliadis, and P. Macheras The heterogeneous course of drug transit through the body Trends Pharmacol. Sci. 25 2004 140 146 (Pubitemid 38264504)
45. A. Dokoumetzidis, K. Kosmidis, P. Argyrakis, and P. Macheras Modeling and monte Carlo simulations in oral absorption Basic Clin. Pharmacol. Toxicol. 96 2005 200 205 (Pubitemid 40387996)
46. A. Dokoumetzidis, G. Valsami, and P. Macheras Modeling and simulation in drug absorption processes Xenobiotica 37 2007 1052 1065 (Pubitemid 350035540)
47. A. Dokoumetzidis, V. Papadopoulou, G. Valsami, and P. Macheras Development of a reaction-limited model of dissolution: Application to official dissolution tests experiments Int. J. Pharm. 355 2008 114 125
48. A. Dokoumetzidis, and P. Macheras Fractional kinetics in drug absorption and disposition proecesses J. Pharmacokinet. Pharmacodyn. 36 2009 165 178
49. A. Dokoumetzidis, R. Magin, and P. Macheras Fractional kinetics in multi-compartmental systems J. Pharmacokinet. Pharmacodyn. 37 2010 507 524
50. A. Dokoumetzidis, R. Magin, A. Dokoumetzidis, R. Magin, P. Macheras, and P. Macheras A commentary on fractionalization of multi-compartmental models J. Pharmacokinet. Pharmacodyn. 37 2010 203 207
51. A. Dokoumetzidis, and P. Macheras The changing face of the rate concept in biopharmaceutical sciences: from classical to fractal and finally to fractional Pharm. Res. 28 2011 1229 1232
52. C.L. Ehlers, J. Havstad, D. Prichard, and J. Theiler Low dosed of ethanol reduce evidence for nonlinear structure in brain activity Neuroscience 18 1998 7474 7486 (Pubitemid 28425830)
53. A. Eke, P. Herman, L. Kocsis, and L.R. Kozar Fractal characterization of complexity in temporal physiological signals Physiol. Meas. 23 2002 R1 R38
54. J. Esquena, C. Solans, and J. Llorens Nitrogen sorption studies of silica particles obtained in emulsion and microemulsion media J. Colloid Interface Sci. 225 2000 291 298 (Pubitemid 30313905)
55. D. Farin, and D. Avnir Use of fractal geometry to determine effects of surface morphology on drug dissolusion J. Pharm. Sci. 81 1992 54 57
56. E. Fernández, and H.F. Jelinek Use of fractal theory in neuroscience: methods, advantages, and potential problems Methods 24 2001 309 321 (Pubitemid 32848401)
57. A. Fini, G. Fazio, M.J. Fernández-Hervás, M.A. Holgado, and A.M. Rabasco Fractal analysis of sodium cholate particles J. Pharm. Sci. 85 1996 971 975 (Pubitemid 26300226)
58. A. Fini, M.J. Fernández-Hervás, M.A. Holgado, L. Rodriguez, C. Cavallari, N. Passerini, and O. Caputo Fractal analysis of beta-cyclodextrin-indomethacin particles compared by ultrasound J. Pharm. Sci. 86 1997 1303 1309 (Pubitemid 27486106)
59. A. Fini, F. Ospitali, G. Zoppetti, and N. Puppini ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles Pharm. Res. 25 2008 2030 2040
60. A. Fini, M.A. Holgado, L. Rodriguez, and C. Cavallari Ultrasound-compacted indomethacin/polyvinylpyrrolidone systems: effect of compaction process on particle morphology and dissolution behavior J. Pharm. Sci. 91 2002 1880 1890 (Pubitemid 34810533)
61. S.R. Forrest, and T.A. Witten Long- range correlations in smoke particle aggragates J. Phys. A: Math. Gen. 12 1979 L109 L117
62. K. Gardikis, S. Hatziantoniou, M. Signorelli, M. Pusceddu, M. Micha-Screttas, A. Schiraldi, C. Demetzos, and D. Fessas Thermodynamical and structural characterization of Liposomal-Locked in Dendrimers as drug carriers Colloids Surf. B Biointerfaces 81 2010 11 19
63. K. Gardikis, C. Tsimplouli, K. Dimas, M. Micha-Screttas, and C. Demetzos New chimeric advanced Drug Delivery nano System (chi-aDDnSs) as doxorubicin carriers Int. J. Pharm. 402 2010 231 237
64. K. Gardikis, D. Fessas, M. Signorelli, K. Dimas, C. Tsimplouli, M. Ionov, and C. Demetzos A new chimeric drug delivery nano system (chi-aDDnS) composed of PAMAM G 3.5 dendrimer and liposomes as doxorubicin's carrier. In vitro pharmacological studies JNN 5 2011 3764 3772
65. E.R. Gasilova, G.N. Matveeva, G.P. Aleksandrova, B.G. Sukhov, and B.A. Trofimov Colloidal aggregates of Pd nanoparticles supported by larch arabinpgalactan J. Phys. Chem. B 117 7 2013 2134 2141
66. A. Garfinkel, M. Spano, W. Ditto, and J. Weiss Controlling cardiac chaos Science 257 1992 1230 1235
67. M. Gaumet, A. Vargas, R. Gurny, and F. Delie Nanoparticles for drug delivery: the need for precision in reporting particles size parameters Eur. J. Pharm. Biopharm. 69 2008 1 9 (Pubitemid 351467152)
68. S.E. Geneser, R.M. Kirby, and R.S. MacLeod Application of stochastic finite element methods to study the sensitivity of ECG forward modeling to organ conductivity IEEE Trans. Biomed. Eng. 55 2008 31 40 (Pubitemid 350308416)
69. M. Goldberd, R. Langer, and X. Jia Nanostructured materials for applications in drug delivery and tissue engineering J. Biomater. Sci. Polym. Ed. 18 2007 241 268 (Pubitemid 46403135)
70. A.E. González, F. Martínez-López, A. Moncho-Jordá, and R. Hildalgo-Alvarez Two-dimensiomal colloidal aggregation: concentration J. Colloid Interface Sci. 246 2002 227 234
71. S.E. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, M.E. Napier, and J.M. DeSimone The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U.S.A. 105 2008 11613 11618
72. G. Gregoriadis, E.J. Wills, C.P. Swain, and A.S. Tavill Drug-carrier potential of liposomes in cancer chemotherapy Lancet 1 1974 1313 1316
73. J. Gregory Monitoring particle aggregation processes Adv. Colloid Interface Sci. 147-148 2009 109 123
74. M.J. Grogan, L. Rotkina, and H.H. Bau In situ liquid-cell electron microscopy of colloid aggregation and growth dynamics Phys. Rev. E83 2011 1 5
75. I.W. Hamley Nanotechnology with soft materials Angew. Chem. Int. Ed. 42 2003 1692 1712 (Pubitemid 36569226)
76. Y.M. Harshe, and M. Lattuada Viscosity contribution of an arbitraty shape rigid aggregate to a dilute suspension J. Colloid Interface Sci. 367 2012 83 91
77. Y.M. Harshe, L. Ehrl, and M. Lattuada Hydrodynamic properties of rigid fractal aggregates of arbitrary morphology J. Colloid Interface Sci. 352 2010 87 98
78. M. Hadjidemetriou, N. Pippa, S. Pispas, and C. Demetoz Incorporation of dimethoxycurcumin into charged liposomes and the formation kinetics of fractal aggregates of uncharged vectors J. Liposome Res. 23 2 2013 94 100
79. M.E. Helgeson, S.E. Moran, H.Z. An, and P.S. Doyle Mesoporous organohydrogels from thermogelling photocrosslinkable nanoemulsions Nat. Mater. 11 2012 344 352
80. S. Huang, I. Ernberg, and S. Kauffman Cancer attractors: a system view of tumors from a gene network dynamics and development perspective Semin. Cell. Dev. Biol. 20 2009 869 876
81. X. Huang, X. Teng, D. Chen, F. Tang, and J. He The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function Biomaterials 31 2010 348 438
82. G.A. Hughes Nanostructure-mediated drug delivery Nanomedicine 1 2005 22 30 (Pubitemid 43963612)
83. G. Iezzi, G. Aprile, D. Tripodi, A. Scarano, A. Piatelli, and V. Perrotti Implant surface topographies analyzed using fractal dimension Implant Dent. 20 2011 131 138
84. M.A. Igbal, S. Md, J.K. Sahni, S. Baboota, S. Dang, and J. Ali Nanostructured lipid carriers system: recent advances in drug delivery J. Drug Target 20 10 2012 813 830
85. I. IIias, N.A. Vgontzas, A. Provata, and G. Mastorakos Complexity and non-linear description of diurnal cortisol and growth hormone secretory patterns before and after sleep deprivation Endocr. Regul. 36 2002 63 72
86. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomedicine 1 2006 297 315
87. I.P. Janecka Cancer control through principles of systems science, complexity, and chaos theory: a model Int. J. Med. Sci. 4 2007 164 173 (Pubitemid 46879083)
88. H.K. Janssen, and O. Stenull Distribution functions in percolation problems Phys. Rev. E Stat. Nonlin Soft Matter Phys. 79 2009 011128
89. H.K. Janssen, and O. Stenull Diluted networks of nonlinear resistors and fractal dimensions of percolation clusters Phys. Rev. E Stat. Phys. Plasmas Fluids Relat. Interdiscip. Topics 61 2000 4821 4834
90. J.M. Jasmine, and E. Prasad Fractal growth of PAMAM dendrimers aggregate and its impact on the intrinsic emission properties J. Phys. Chem. B 114 2010 7735 7742
91. H.F. Jelinek, and E. Fernandez Neurons and fractals: how reliable and useful are calculations of fractal dimensions? J. Neurosci. Methods 81 1998 9 18 (Pubitemid 28293713)
92. J. Jeong, D.J. Kim, J.H. Chae, S.Y. Kim, H.J. Ko, and I.K. Paik Nonlinear analysis of the EEG of schizophrenics with optimal embedding dimension Med. Eng. Phys. 20 1998 669 676 (Pubitemid 29090699)
93. R. Jullien Aggregation phenomena and fractal aggregates Contmp. Phys. 28 1987 477 493
94. K. Jurczyszyn, B.J. Osiecka, and P. Ziólkowski The use of fractal dimension analysis in estimation of blood vessels shape in transplantable mammary adenocarcinoma in Wistar rats after photodynamic therapy combined with cystein protease inhibitors Comput. Math. Methods Med. 2012 793291 793297
95. A. Kalampokis, P. Argyrakis, and P. Macheras Heterogeneous tube model for the study of small intestinal transit flow Pharm. Res. 16 1999 87 91 (Pubitemid 29047462)
96. A. Kalampokis, P. Argyrakis, and P. Macheras A heterogeneous tune model of intestinal absorption based on probalistic concepts Pharm. Res. 16 1999 1764 1769 (Pubitemid 29530411)
97. V. Kanniah, P. Wu, Mandzy, and E.A. Grulke Fractal analysis as a complimentary technique for characterizing nanoparticle size distributions Powder Technol. 226 2012 189 198
98. A. Kamiya, and T. Takahashi Qunatitative assessments of morphological and functional properties of biological trees based on their fractal nature J. Appl. Physiol. 102 2007 2315 2323 (Pubitemid 47080766)
99. V. Karalis, L. Claret, A. Illiadis, and P. Macheras Fractal volume of drug distribution: it scales proportionally to body mass Pharm. Res. 18 2001 1056 1060 (Pubitemid 32799955)
100. V. Karalis, and P. Macheras Drug disposition viewed in terms of the fractal volume of distribution Pharm. Res. 19 2002 696 703 (Pubitemid 34553680)
101. T. Kim, C.H. Lee, S.W. Joo, and K. Lee Kinetics of gold nanoparticle aggregation: Experiments and modeling J. Colloid Interface Sci. 318 2008 143 238
102. Y. Kimori, E. Katayama, N. Morone, and T. Kodoma Fractal dimension analysis and mathematical morphology of structural changes in actin filaments imaged by electron microscopy J. Struct. Biol. 176 2011 1 8
103. R.D. King, B. Brown, M. Hwang, T. Jeon, and A.T. George Fractal dimension analysis of the cortical ribbon in mild Alzheimer's disease Neuroimage 52 2010 471 479
104. S.A. Khan, and N.J. Zoeller Dynamic rheological behavior of flocculated sumed silica suspensions J. Rheol. 37 1993 1225 1235
105. H.P. Koch The concept of fractals in the pharmaceutical sciences Pharmazie 48 1993 643 659 (Pubitemid 23311080)
106. K.N. Kontogiannopoulos, A.N. Assimopoulou, S. Hantziantoniou, K. Karatassos, C. Demetzos, and V.P. Papageorgiou Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology Int. J. Pharm. 422 2012 381 389
107. R. Kopelman Fractal reaction kinetics Science 241 1988 1620 1626
108. K. Kosmidis, P. Argyrakis, and P. Macheras A reappraisal of drug release law using Monte Carlo simulations: the prevalence of Weibull function Pharm. Res. 20 2003 988 995 (Pubitemid 36774268)
109. K. Kosmidis, E. Rinaki, P. Argyrakis, and P. Macheras Analysis of case II drug transport with radial and axial release from cylinders Int. J. Pharm. 254 2003 183 188 (Pubitemid 36298827)
110. K. Kosmidis, V. Karalis, P. Argyrakis, and P. Macheras Michaelis-Menten kinetics under spatially constrained conditions: application to mibefradisl pharmacokinetics Biophys. J. 87 2004 1498 1506 (Pubitemid 39167009)
111. K. Kostarelos Nanorobots for medicine: how close are we? Nanomedicine 5 2010 341 342
112. C.G. de Kruif, T. Huppertz, V.S. Urban, and A.V. Petukhov Casein micelles and their internal structure Adv. Colloid Interface Sci. 171-172 2012 36 52
113. L. Lacerda, M.A. Herrero, k. Venner, A. Bianco, M. Prato, and K. Kostarelos Carbon-nanotube shape and individualization critical for renal excretion Small 4 2008 1130 1132
114. E. Laffon, K. Suárez, Y. Berthoumieu, D. Ducassou, and R. Marthan Normalization in quantitative [18F]FBG PET imaging: The "body surface area" may be volume Phys. Med. Biol. 51 2006 N47 N50
115. M. Lattuada, H. Wu, and M. Morbidelli Estimation of fractal dimension of colloidal gels in the presence of multiple scattering Phys. Rev. E 64 2001 1 7
116. M. Lattuada, H. Wu, and M. Morbidelli A simple model for the structure of fractal aggregates J. Colloid Interface Sci. 268 2003 106 120 (Pubitemid 37383736)
117. M. Lattuada, P. Sandkühler, H. Wu, J. Sefcik, and M. Morbidelli Aggregation kinetics of polymer colloids in reaction limited regime: experiments and simulations Adv. Colloid Interface Sci. 103 2003 33 56
118. X. Li, Y. Fan, and F. Watari Current investigation into carbon nanotubes for biomedical application Biomed. Mater. 5 2010 022001
119. M.Y. Lin, H.M. Lindsay, D.A. Weitz, R. Klein, R.C. Ball, and P. Meakin Universal reaction-limited colloid aggregation Nature 339 1989 360 362
120. O. Link, D.R. Snelling, K.A. Thomson, and G.J. Smallwood Development of absolute intensity multi-angle light scattering for determination of polydisperse soot aggregate properties Proc. Combust. Inst. 33 2011 847 854
121. Y. Liu, J. Tan, A. Thomas, D. Ou-Yang, and V.R. Muzykantov The shape of things to come: importance of design in nanotechnology for drug delivery Ther. Deliv. 2 2012 181 194
122. M.R. Longmire, M. Ogawa, P.L. Choyke, and H. Kobayashi Biologically optimized nanosized molecules and particles: more than just size Bioconjug. Chem. 22 2011 993 1000
123. G.A. Losa, and T.F. Nonnenmacher Self-similarity and fractal irregularity in pathologic tissues Mod. Pathol. 9 1996 174 182 (Pubitemid 26126540)
124. P. Macheras Carrier-mediated transport can obey fractal kinetics Pharm. Res. 12 1995 541 548
125. P. Macheras A fractal approach to heterogeneous drug distribution: calcium pharmacokinetics Pharm. Res. 13 1996 663 670 (Pubitemid 26156216)
126. P. Macheras, P. Argyrakis, and C. Polymilis Fractal geometry, fractal kinetics and chaos en route to biopharmaceutical sciences Eur. J. Drug Metab. Pharmacokinet. 21 1996 77 86 (Pubitemid 26246150)
127. P. Macheras, and P. Argyrakis Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity? Pharm. Res. 14 1997 842 847 (Pubitemid 27326976)
128. P. Macheras, and A. Dokoumetzidis On the heterogeneity of drug dissolution and release Pharm. Res. 17 2000 108 112 (Pubitemid 30158357)
129. P. Macheras, and A. Iliadis Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches 2006 Springer New York
130. M. Mackey, and U. AnDerheiden The dynamics of recurrent inhibition J. Math. Biol. 19 1984 211 225 (Pubitemid 14118496)
131. B.B. Mandelbrot The Fractal Geometry of Nature 1982 Freeman & Co San Francisco
132. P. Manoj, A.J. Fillery-Travis, A.D. Watson, D.J. Hibberd, and M.M. Robins Characterization of polydisperse depletion-flocculated emulsion J. Colloid Interface Sci. 228 2000 200 206
133. P.D. Marcato, and N. Durán New aspects of nanopharmaceuticals delivery systems J. Nanosci. Nanotechnol. 8 2008 1 14
134. R.E. Marsh, and J.A. Tuszyński Fractal michaelis - menten kinetics under steady state conditions: Application to mibefradil Pharm. Res. 23 2006 2760 2767 (Pubitemid 44885364)
135. L. Martínez, R. Villalobos, M. Sáncchez, J. Cruz, A. Ganem, and L.M. Melgoza Monte Carlo simulations for the study of drug release from cylindrical matrix systems with an inert nucleus Int. J. Pharm. 369 2009 38 46
136. L. Mazzola Commercializing nanotechnology Nat. Biotechnol. 21 2003 1137 1143 (Pubitemid 37186165)
137. J.G. McNally, and D. Mazza Fractal geometry in the nucleus EMBO J. 29 2010 1 3
138. P. Meakin The structure of two-dimensional Witten-Sander aggregates J. Phys. A Math. Gen. 19 1983 L661 L666
139. P. Meakin Formation of fractal cluster and networks by irreversible diffusion-limited aggregation Phys. Rev. Lett. 51 1983 1119 1122
140. P. Meakin A new model for biological pattern formation J. Theor. Biol. 118 1986 101 113 (Pubitemid 16153612)
141. Z. Meng, S.M. Hashmi, and M. Elimelech Aggregation rate and fractal dimension of fullerene nanoparticles via simultaneous multiangle static and dynamic light scattering measurement J. Colloid Interface Sci. 392 2013 27 33
142. L. Metulio, M. Ferrone, A. Coslanich, S. Fuchs, M. Fermeglia, M.S. Paneni, and S. Pricl Polyamidoamine (Yet not PAMAM) Dendrimers as Bioinspired Materials for Drug Delivery: Structure-Activity Relationships by Molecular Simulations Biomacromolecules 5 2004 1371 1378 (Pubitemid 39089738)
143. J. Milton, and D. Black Dynamic diseases in neurology and psychiatry Chaos 5 1995 8 13
144. L.A. Mirny The fractal globule as a model of chromatin architecture in the cell Chromosome Res. 19 1 2011 37 51
145. B. Mishra, B. Bhavesh, Patel, and S. Tiwari Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery Nanomedecine 6 2010 9 24
146. S.M. Moghimi, and J. Szebeni Stealth liposomes and long-circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478 (Pubitemid 37237636)
147. P.A. Moreno, P.E. Vélez, E. Martínez, L.E. Garreta, N. Díaz, S. Amador, I. Tischer, J.M. Gutiérrez, A.K. Naik, and F. García The human genome: a multifractal analysis BMC Genom. 12 2011 506 523
148. M.S. Mufamadi, V. Pillay, Y.E. Choonara, L.C. Du Toit, G. Modi, D. Naidoo, and V.M.K. Ndesendo A review on composite liposomal technologies for specialized drug delivery J. Drug Deliv. 2011 2011 939851 939870
149. S. Nayak, and L.A. Lyon Soft nanotechnology with soft nanoparticles Angew. Chem. Int. Ed. Engl. 44 2005 7686 7708 (Pubitemid 41759533)
150. B. Nyström, A.L. Kjøniksen, N. Beheshti, A. Maleki, K. Zhu, K.D. Knudsen, R. Pamies, J.G. Hernández Cifre, and J. García de la Torre Characterization of polyelectrolyte features in polysaccharide systems and mucin Adv. Colloid Interface Sci. 158 2010 108 118
151. T. Ogasawara, K. Izawa, N. Hattori, H. Okabayashi, and C.J. O'Connor Growth process for fractal polymer aggregates formed by perfluorooctyltrimethoxysilane. Time-resolved small-angle X-ray scattering study Colloid Polym. Sci. 278 2000 293 300 (Pubitemid 30229751)
152. D.E. Owens, and N.A. Peppas Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)
153. V. Papadopoulou, K. Kosmidis, M. Vlachou, and P. Macheras On the use of the Weibull function for the discernment of drug release mechanisms Int. J. Pharm. 309 2006 44 50 (Pubitemid 43129463)
154. M. Panouillé, D. Durand, T. Nicolai, E. Larquet, and N. Boisset Aggregation and geletion of micellar casein particles J. Colloid Interface Sci. 287 2005 85 93 (Pubitemid 40725646)
155. I. Pantic, L. Harhaji-Trajkovic, A. Pantovic, M.T. Milisevic, and V. Trajkovic Cahnges in fractal dimension and lacunarity as early marker of UV-induced apoptosis J. Theor. Biol. 303 2012 87 92
156. A. Papagiannaros, K. Dimas, G.T. Papaioannou, and C. Demetzos Doxorubicin-PAMAM dendrimers complec attached to liposomes: Cytotoxic studies against human cancer cell lines Int. J. Pharm. 302 2005 29 38 (Pubitemid 41242749)
157. L.M. Pereira Fractal pharmacokinetics Comput. Math. Methods Med. 11 2010 161 184
158. V.J. Pinfield, E. Dickinson, and M.J.W. Povey Modeling of combined creaming and flocculation in emulsions J. Colloid Interface Sci. 186 1997 80 89 (Pubitemid 27470987)
159. N. Pippa, C. Demetzos, and E. Danezis The formalism of fractal aggregation phenomena of colloidal drug delivery systems J. Liposome Res. 22 2012 55 61
160. N. Pippa, S. Pispas, and C. Demetzos The fractal hologram and elucidation of the structure of liposomal carriers in aqueous and biological media Int. J. Pharm. 430 2012 65 73
161. N. Pippa, S. Pispas, and C. Demetzos The delineation of the morphology of charged liposomal vectors via a fractal analysis in aqueous and biological media: physicochemical and self-assembly studies Int. J. Pharm. 437 2012 264 274
162. N. Pippa, E. Kaditi, S. Pispas, and C. Demetzos PEO-b-PCL/DPPC chimeric nanocarriers: self-assembly aspects in aqueous and biological media and drug incorporation Soft Matter 9 2013 4073 4082
163. N. Pippa, M. Merkouraki, S. Pispas, and C. Demetzos DPPC:MPOx chimeric advanced Drug Delivery nanosystems (chi-aDDnSs): physicochemical and structural characterization, stability and drug release studies Int. J. Pharm. 450 2013 1 10
164. N. Pippa, E. Kaditi, S. Pispas, and C. Demetzos DPPC/poly(2-methyl-2- oxazoline)-grad-poly(2-phenyl-2-oxazoline) chimeric nanostructures as potential drug nanocarriers J. Nanopart. Res. 15 2013 1685
165. S. Pispas, and E. Sarantopoulou Self-assembly in mixed aqueous solutions of amphiphilic block copolymers and vesicle-forming surfactant Langmuir 23 2007 7484 7490 (Pubitemid 47116406)
166. S. Pispas Self-assembles nanostructures in mixed anionic-neutral double hydrophilic block copolymer/cationic vesicle-forming surfactant solutions Soft Matter 7 2011 474 482
167. S. Pispas Vesicular structures in mixed block copolymer/surfactant solutions Soft Matter 7 2011 8697 8701
168. Z. Racz, and K.T. Vicsek Diffusion-controlled deposition: Cluster statistics and scaling Phys. Rev. Lett. 51 1983 2382 2385
169. R. Ravichandron Nanotechnology-based drug delivery systems Nanobiotechnology 5 2009 17 33
170. S. Roldán-Vargas, R. Barnabas-Rodrígez, A. Martín-Molina, M. Quesada-Pérez, J. Estelrich, and J. Callejas-Fernández Growth of lipid vesicle structures: from surface fractals to mass fractals Phys. Rev. E 78 2008 1 4
171. S. Roldán-Vargas, R. Barnabas-Rodrígez, M. Quesada-Pérez, J. Estelrich, and J. Callejas-Fernández Surface fractals in liposome aggregation. The American physical society Phys. Rev. 79 2009 1 14
172. M. Rowland, C.R. Noe, D.A. Smith, G.T. Tucker, D.J. Cromellin, C.C. Peck, M.L. Rocci Jr., and L. Besançon Impact of the pharmaceutical sciences on the health care: a reflection over the past 50 years J. Pharm. Sci. 101 2012 4075 4099
173. 2+ Eur. Phys. J. E 24 2007 201 210 (Pubitemid 50002814)
174. J. Sabín, G. Prieto, J.M. Ruso, P.V. Messina, and F. Sarmiento Aggregation of liposomes in presence of La3+: a study of the fractal dimension Phys. Rev. E 76 2007 1 7
175. M. Saladin El Naschie Nanotechnology for the developing world Chaos, Solitons, Fractals 30 2000 769 773
176. N.M. Schaeublin, L.K. Braydich-Stolle, E.L. Maurer, K. Park, R.I. MacCuspie, A.R. Afrooz, R.A. Vaia, N.B. Saleh, and S.M. Hussain Does shape matter? Bioeffects of gold nanomaterials in a human skin cell model Langmuir 28 2012 3248 3258
177. C. Silva, I.R. Pimentel, A. Andreade, J.P. Foreid, and E. Ducla-Soares Correlation dimension mapsof EEG from epileptic absences Brain Topogr. 11 1999 201 209 (Pubitemid 29178843)
178. T.G. Smith Jr., G.D. Lange, and W.B. Marks Fractal methods and results in cellular morphology-dimensions, lacunarity and multifractals J. Neurosci. Methods 69 1996 123 136 (Pubitemid 26377770)
179. K. Sotiriou, S. Pispas, and N. Hadjichristidis Controlling the colloidal behavior of styrene-isoprene diblock copolymers by selective end functionalization Colloids Surf. A: Physicochem. Eng. Aspects 293 2007 51 57 (Pubitemid 44937598)
180. G.R. Souza, F.I. Staquicini, D.R. Christianson, M.G. Ozawa, J. Houston Miller, R. Pasqualini, and W. Arap Combinatorial targeting and nanotechnology applications Biomed. Microdev. 12 2010 597 606
181. K.J. Stam, D.L. Tavy, B. Jelles, H.A. Achtereekte, J.P. Slaets, and R.W. Keunen Non-linear dynamical analysis of multichannel EEG: Clinical applications in dementia and Parkinson's disease Med. Eng. Phys. 7 1994 141 150
182. C.T. Streba, D. Pirici, C.C. Vere, L. Mogoanta, V. Comanescu, and I. Rogoveanu Fractal analysis differentiation of nuclear and vascular patterns in hepatocellular carcinomas and hepatic metastasis Rom. J. Morphol. Embryol. 52 2011 845 854
183. D.J. Swenson, S.E. Geneser, J.G. Stinstra, R.M. Kirby, and R.S. MacLeod Cardiac position sensitivity study in the electrocardiographic forward problem using stochastic collocation and boundary element methos Ann. Biomed. Eng. 39 2011 2900 2910
184. M. Tambasco, M. Eliasziw, and A.M. Magliocco Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival J. Transl. Med. 8 2010 140
185. S. Tang, J.M. Preece, C.M. McFarlane, and Z. Zhang Fractal morphology and breakage of DLCA and RLCA aggregates J. Colloid Interface Sci. 221 2000 114 123 (Pubitemid 30046552)
186. A. Thill, S. Veerapaneni, B. Simon, M. Wiesner, J.Y. Bottero, and D. Snidaro Determination of structure of aggregates by confocal scanning laser microscopy J. Colloid Interface Sci. 204 1998 357 362 (Pubitemid 28383519)
187. R. Thibert, M. Akbarieh, and R. Tawashi Application of fractal dimension to the study of the surface ruggedness of granular solids and excipients J. Pharm. Sci. 77 1988 724 726 (Pubitemid 19030300)
188. I.M. Tolic, E. Mosekilde, and J. Sturis Modeling the insulin-glucose feedback system. The significant of pulsatile insulin secretion J. Theor. Biol. 207 2000 361 375
189. D.A. Tomalia In quest of a systematic framework for unifying and definig nanoscience J. Nanopart. Res. 11 2009 1251 1310
190. B. Topp, K. Promislow, G. Devries, R.M. Miura, and D.T. Finegood A model of β-cells mass, insulin and glucose kinetics: pathways to diabetes J. Theor. Biol. 206 2000 605 619
191. V.P. Torchilin Micellar Nanocarriers:Pharmaceutical perspectives Pharm. Res. 21 2007 1 15
192. V.P. Torchilin Targeted polymeric micelles for delivery of poorly soluble drugs Cell. Mol. Life Sci. 61 2004 2549 2559 (Pubitemid 39591627)
193. A. Tromelin, J.C. Gnanou, C. Andrès, Y. Pourcelot, and B. Chaillot Study of morphology of reactive dissolution interface using fractal geometry J. Pharm. Sci. 85 1996 924 928 (Pubitemid 26300217)
194. A. Tromelin, G. Hautbout, and Y. Pourcelot Application of fractal geometry to dissolution kinetic study of a sweetener excipient Int. J. Pharm. 224 2001 131 140 (Pubitemid 32706492)
195. S. Vamvakas, J. Martinaldo, R. Pita, and M. Isaak On the edge of new Technologies (advanced therapies, nanomedicines) Drug Discovery Today: Technol. 8 2011 e21 e28
196. D. Verotta Fractional dynamics pharmacokinetics-pharmacodynamic models J. Pharmacikinet. Pharmacodyn. 37 2010 257 276
197. C. Wangner, and D. Person Chaos in the cardiovascular system: An update Cardiovscular Res. 40 1998 236 265
198. V. Wagner, A. Dullaart, A.K. Bock, and A. Zweck The emerging nanomedicine landscape Nat. Biotechnol. 24 2006 1211 1217 (Pubitemid 44564760)
199. J. Wang, J.D. Byrne, M.E. Napier, and J.M. DeSimone More effective nanomedicines through particle design Small 7 2011 1919 1931
200. M. Weiss, P. Li, and M.S. Roberts Estimation of sinusoidal flow heterogeneity in normal and diseased rat livers from tracer dilution data using a fractal model Microcirculation 19 2012 723 728
201. M. Weiss Fractal structure of the liver: effect on drug elimination J. Pharmacokinet. Pharmacodyn. 40 2013 11 14
202. G.B. West, J.H. Brown, and B.J. Enquist A general model for the origin of allometric scaling laws in biology Science 276 1997 122 126 (Pubitemid 27161259)
203. G.B. West, J.H. Brown, and B.J. Enquist The fourth dimension of life: fractal geometry and allometric scaling of organisms Science 248 1999 1677 1679 (Pubitemid 29291379)
204. T.A. Witten, and L.M. Sander Diffusion-Limited Aggregation, a kinetic critical phenomena Phys. Rev. Lett. 47 1981 1400 1403
205. T.A. Witten, and L.M. Sander Diffusion-Limited Aggregation Phys. Rev. B 27 1983 5686 5697
206. G.M. Whitesides, and D.J. Lipomi Soft nanotechnology: structure vs. function Faraday Discuss. 143 2009 373 384
207. G.M. Whitesides, and B. Grzybowski Self-assembly at all scales Science 295 2007 2418 2421 (Pubitemid 34270248)
208. C.Y. Wu, S. Tarimala, and L.L. Dai Dynamics of charged microparticles at oil-water interfaces Langmuir 22 2006 2112 2116 (Pubitemid 43382846)
209. B. Wu, Y. Lin, Z. Zhang, and G. Chen Trapping in dendrimers and regular hyperbranched polymers J. Chem. Phys. 137 2012 044903 044911
210. J.W. Yoo, E. Chambers, and S. Mitragorti Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects Curr. Pharm. Des. 16 2010 2298 2307